Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xlear vs. Placebo for Acute COVID-19
NCT04858620Phase 3Withdrawn
- Sponsor
- Larkin Community Hospital
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
A Phase 3 trial of Xlear Nasal Spray in coronavirus disease 2019 (COVID-19), sponsored by Larkin Community Hospital. Planned start Aug 2020; status: withdrawn.
02
Drugs
Xlear Nasal Spray
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04858620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858620.